The Aura CL: Rapid subvisible particle analysis for cell therapy manufacturing

The measurement of particles in cell therapy production has long presented challenges, particularly since the drug product itself is composed of particles, compounding the complexities in the process.

Waters' Aura CL System is the pioneering system that, in contrast to traditional methods, swiftly identifies and differentiates cells from protein aggregates or harmful particles, while also delivering all necessary cytometric functions. Aura CL counts, identifies, and assesses the viability of cells all in a single, simple assay.

Driven by cutting-edge technology, the Waters Aura CL System serves as the premier tool for identifying, quantifying, and characterizing subvisible particle contaminants introduced during cell therapy manufacturing. This allows users to obtain high-throughput insights earlier in the discovery phase, facilitating the development of cell therapies in a faster, more intelligent, and safer manner.

Specifications

Source: Waters | Wyatt Technology

Specifications
Imaging Area 24.6 mm2
Optics 4x and 10 objectives
Minimum volume 5 µL (assay dependent)
Resolution 1.0 pixel/µm
Detectable size range Range from >1 µm (ECD) to <5 mm (ECD)
BMI read time 1 minute/sample
FMM read time 30 seconds/sample
Software Particle Vue 4.x all-in-one Software suite (image capture and analysis)

Overview

  • Detect and quantify residual Dynabeads: The Aura CL System simplifies the process of locating and counting DynabeadsTM. In contrast to conventional techniques, which can be subjective, labor-intensive, inaccurate, and prone to mistakes, this advanced, fully automated instrument enables users to achieve precise counts at a rapid pace.
  • ID cells and non-cells: Instead of dedicating hours to manually sifting through images or mastering intricate machine learning frameworks, the Aura CL System facilitates the straightforward identification of cells versus non-cell aggregates right from the start.
  • Analyze minimal volumes: Users only require 5 µL of sample, which permits earlier characterization of particles and cells during development.
  • Discover more with cutting-edge technology: By utilizing background-corrected membrane imaging (BMI) and fluorescence membrane microscopy (FMM), the Aura CL System conducts cell viability assays with clear cell identification for 96 samples of 40 μL each in under an hour.

Best used for rapid and conclusive characterization of low-volume particles in the development and manufacturing processes of cell therapy.

The first and only solution to detect and count Dynabeads

Residual Dynabeads present in a final product can undermine potency, necessitating bead analysis to adhere to stringent quality standards. Nevertheless, the application of manual hemocytometry for the detection of residual Dynabeads has proven to be inconsistent due to the difficulty in distinguishing between beads and cells.

The Waters Aura CL System employs side illumination membrane imaging (SIMI) to efficiently and accurately identify residual Dynabeads with both specificity and sensitivity, thereby reducing time and costs. This unique automated solution mitigates human errors, ensuring compliance with the highest quality standards for cell therapy lot release assays.

BMI revealing cells and Dynabeads, whereas SIMI reveals only Dynabeads.

BMI reveals cells and Dynabeads, whereas SIMI reveals only Dynabeads. Image Credit: Waters | Wyatt Technology 

Get high-throughput, definitive identification of viable cells

The high-throughput and accurate identification of viable cells is essential in the manufacturing of cell therapies. Nevertheless, achieving this crucial product-purity parameter has posed a challenge, as traditional methods are labor-intensive and complex - until now.

The Aura CL System eliminates uncertainty in cell viability evaluations. Users can now disregard unreliable methods, such as morphology and spectroscopy, along with intricate machine learning libraries, for assessing the sample's composition.

By labeling the particles or groups of interest with fluorescent dyes or antibodies, it becomes feasible to distinguish between cellular and non-cellular components, as well as protein and non-protein elements within complex samples.

With Aura CL System, you can achieve high-throughput and definitive identification of viable cells and take the guesswork out of cell viability assessments.

With the Aura CL System, you can achieve high-throughput and definitive identification of viable cells and take the guesswork out of cell viability assessments. Image Credit: Waters | Wyatt Technology 

Other Equipment by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.